Abstract 2071P
Background
The objective of this study is to identify the major issues and concerns of cancer patients in Korea related to cancer, anti-cancer therapy, and patient care that are mentioned on social media.
Methods
We collected data from open-access forums, blogs, and social networking sites using professional ISO 20252 certified online access tools. We searched the terms “cancer”, "cancer treatment", and “patient care” and collected social media posts between October 2021 and September 2022, excluding spam and advertisements.
Results
Total 169,575 social media posts were collected. Among the posts, 51% were related to cancer symptoms, concerns following diagnosis, and cancer etiology, while 39% discussed treatment methods, treatment-related side effects, novel therapies, as well as costs. The remaining posts centered on how to manage in daily life. The most frequently mentioned cancer types were breast, lung, colorectal, stomach, and liver cancer, consistent with common cancers in Korea. Concerning the difficulties experienced, 52% reported physical challenges, 42% reported emotional challenges, and 6% discussed daily life issues, such as diet and sexual relationships. Additionally, patients had high expectations for immune checkpoint inhibitors. Patients tend to view clinical trial participation as an alternative when conventional treatments are ineffective and see it positively as a way to participate without financial burden. However, some express safety concerns. Patients frequently shared tips for managing daily life on social media, such as healthy eating, taking supplements, and light exercise to maintain physical strength.
Conclusions
Our findings suggest that cancer patients in Korea frequently use social media for information. The high frequency of emotional difficulties mentioned indicates that patients face persistent emotional challenges throughout the cancer journey. This study underscores the potential benefits of analyzing social media posts by cancer patients, providing valuable insights for healthcare professionals and patients. Moreover, it emphasizes the importance of the developing and delivering professional information on daily life management for cancer patients.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Korean Society of Medical Oncology.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
2096P - Morphine titration with intravenous patient-controlled analgesia for severe cancer pain (Mr.TIPS)
Presenter: Seok Jae Huh
Session: Poster session 06
2097P - Incidence, risk factors (RFs) and management of oral mucositis (OM) in patients (pts) treated with a fluoropyrimidines (FP)-based therapy (tp): A retrospective, monocentric experience
Presenter: Fiorella Manfredi
Session: Poster session 06
2098P - The impact of concomitant use of non-opioid analgesics and immune checkpoint inhibitors on survival in lung cancer patients: A Hong Kong population-based cohort study
Presenter: Zheng-Hao Ye
Session: Poster session 06
2099P - The role of ambulatory blood pressure measurement in TKI-induced arterial hypertension diagnosis
Presenter: Elina Khachaturian
Session: Poster session 06
2100P - An exploratory study of the efficacy and safety of hetrombopag in the treatment of thrombocytopenia induced by concurrent or sequential chemoradiotherapy
Presenter: Jun Wang
Session: Poster session 06
2101P - Bleeding Induced by ANtiCAncer drugs (BIANCA) used breast cancer
Presenter: Nicolas Janus
Session: Poster session 06
2102P - Changes in opioid usage after intrathecal morphine pump implantation in patients with terminal cancer (pilot study)
Presenter: Eun Joo Choi
Session: Poster session 06
2103P - Phase Ib, international, dose-escalation study to evaluate the safety, pharmacokinetics (PK) and efficacy of ST-617 a dithiolethione, for the attenuation of oral mucositis (OM) in patients receiving chemoradiation (CRT) for head & neck (H&N) cancer
Presenter: Daniel Osei-Fofie
Session: Poster session 06
2104P - Prevention of taxane chemotherapy induced nail changes and peripheral neuropathy by application of extremity cooling: A prospective single center study with intrapatient comparison
Presenter: Kristen Johnson
Session: Poster session 06
2105P - Prophylactic role of a postbiotic microbiota-stabilizer on abemaciclib-induced diarrhea in breast cancer patients: A pilot application study
Presenter: Rita De Sanctis
Session: Poster session 06